Global Substance Abuse Treatment Market Overview:
Substance Abuse Treatment market is expected to grow in the future due to the rise in the drug awareness campaigns and associated prevention programs and adoption of newer formulations and novel dosage forms. Substance abuse is the repeated harmful use of any substance, including drugs and alcohol. The substances may be legal, prescription drugs or banned substances as well some that arenít even classified as drugs. Technological advancement in the diagnostics industry is boosting the growth of the market.
- Increasing Number of Drug Awareness Campaigns and Prevention Programs
- High Number of Addicted Population
- Technological Advancement in the Diagnostics Industry
- Reluctance of Individuals for Accessing Treatment and Discontinuation of the Behavioral Therapies
- High Usage of Tobacco across the Developing and Developed Nations
- Growing Healthcare Infrastructure in the Developing Economies
- Availability of Cost Effective Treatment Option
- Poor Treatment Compliance in Some Countries
The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations.
Some of the key players profiled in the report are Allergan plc (United States), Sanofi S.A (France), GSK (United Kingdom), Pfizer Inc. (United States), Alkermes (Ireland), Mylan N.V. (United States), Cipla Limited (India), Purdue Pharma L.P. (United States), Reckitt Benckiser Group plc (United Kingdom) and Teva Pharmaceutical (Israel). Analyst at AMA Research see United States Players to retain maximum share of Global Substance Abuse Treatment market by 2026. Considering Market by Distribution Channel, the sub-segment i.e. Hospital Pharmacies will boost the Substance Abuse Treatment market. Considering Market by End User, the sub-segment i.e. Hospitals will boost the Substance Abuse Treatment market.
In Oct 2019, The Trump administration has unveiled a website aimed at helping millions of Americans with substance abuse issues learn about and locate treatment options.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Substance Abuse Treatment market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Substance Abuse Treatment market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Pharmaceutical Companies, Pharmacy Chains/Drug Stores, Drug Suppliers/Traders, Drug Exporters/Importers, Investors, Regulatory and Government Bodies, Upstream Vendors, Downstream Vendors and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.